Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS multicenter study.

Autor: Pérez, Diego Zambrano, Lintis, Alexandru, Taibi, Abdel, Kefleyesus, Amaniel, Noiret, Barbara, Bouillin, Alix, De Meeus, Guillaume, Eveno, Clarisse, Kepenekian, Vahan, Hübner, Martin, Glehen, Olivier, Sgarbura, Olivia A.
Předmět:
Zdroj: European Journal of Surgical Oncology; Feb2024, Vol. 50 Issue 2, pN.PAG-N.PAG, 1p
Databáze: Supplemental Index